Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould ...
Fintel on MSN
Cantor Fitzgerald maintains Bitdeer Technologies Group (BTDR) overweight recommendation
Fintel reports that on December 16, 2025, Cantor Fitzgerald maintained coverage of Bitdeer Technologies Group (NasdaqCM:BTDR) ...
Cantor Fitzgerald lowered the firm’s price target on AMD (AMD) to $300 from $350 and keeps an Overweight rating on the shares ...
Cantor says Hyperliquid is trading infrastructure, not speculative DeFi, with HYPD and PURR offering exposure to fees, ...
Cantor Fitzgerald LP and two affiliate firms escaped claims they unlawfully enforced noncompete provisions in partnership ...
In a report released yesterday, Steven Seedhouse from Cantor Fitzgerald maintained a Buy rating on Innoviva, with a price target of $31.00.
Cantor Fitzgerald has expressed an optimistic outlook for financial markets in the near term, and into 2026. Learn more here.
Eve Holding, Inc. (NYSE:EVEX) is one of the Best Aerospace Stocks to Buy According to Analysts. On December 8, Cantor ...
Robinhood Markets, Inc. (NASDAQ:HOOD) is one of the 14 Most Promising Fintech Stocks to Invest In. On December 11, Cantor ...
Cryptopolitan on MSN
Cantor Fitzgerald reveals Solana ETF investment stake
Cantor Fitzgerald revealed a $1.28 million Solana ETF stake, boosting institutional investor interest immediately.
12d
Cantor has cut its Strategy price target by 60%, but wants you to know everything is going to be OK
Cantor Fitzgerald, a bank with some political ties, is the ninth-biggest shareholder in Strategy, a bitcoin treasury company ...
Cantor Fitzgerald slashed its MSTR price target by 60% but told clients that forced liquidations from Strategy remain an unwarranted concern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback